Julià Blanco Selected Research

Tubulin

5/2022	Transactive Response DNA-Binding Protein (TARDBP/TDP-43) Regulates Cell Permissivity to HIV-1 Infection by Acting on HDAC6.
10/2018	Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julià Blanco Research Topics

Disease

43	Infections 08/2023 - 02/2006
28	COVID-19 03/2024 - 10/2020
12	HIV Infections (HIV Infection) 01/2022 - 03/2006
11	Inflammation (Inflammations) 12/2022 - 04/2010
8	Neoplasms (Cancer) 01/2024 - 12/2016
6	Virus Diseases (Viral Diseases) 01/2022 - 03/2006
6	Viremia 01/2019 - 04/2010
3	Disease Progression 09/2022 - 01/2021
2	Pneumonia (Pneumonitis) 12/2022 - 07/2021
2	Acquired Immunodeficiency Syndrome (AIDS) 09/2022 - 01/2021
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2017 - 02/2013
1	Weight Loss (Weight Reduction) 02/2024
1	Agammaglobulinemia (Hypogammaglobulinemia) 11/2023
1	Coronavirus Infections 08/2023
1	Adenocarcinoma of Lung 05/2023
1	Pain (Aches) 05/2023
1	Headache (Headaches) 05/2023
1	Fatigue 05/2023
1	COVID-19 breakthrough infections 05/2023
1	Syphilis 01/2023
1	Multiple Myeloma 12/2022
1	Smoldering Multiple Myeloma 12/2022
1	Monoclonal Gammopathy of Undetermined Significance 12/2022
1	Type I Syndactyly 04/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Reinfection 12/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2021
1	Common Cold 01/2021

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 03/2024 - 01/2015
12	AntibodiesIBA 02/2024 - 07/2011
10	Neutralizing AntibodiesIBA 01/2023 - 01/2009
8	Glycoproteins (Glycoprotein)IBA 03/2024 - 07/2007
8	AntigensIBA 07/2023 - 03/2008
8	Proteins (Proteins, Gene)FDA Link 05/2023 - 11/2013
7	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2017
7	DNA (Deoxyribonucleic Acid)IBA 07/2020 - 03/2006
5	Immunoglobulin G (IgG)IBA 11/2022 - 01/2017
5	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2016
4	Messenger RNA (mRNA)IBA 12/2022 - 01/2022
4	Raltegravir Potassium FDA Link 01/2020 - 01/2014
3	Monoclonal AntibodiesIBA 02/2024 - 03/2006
3	Antiviral Agents (Antivirals)IBA 08/2023 - 01/2021
3	LectinsIBA 01/2023 - 12/2021
3	Viral ProteinsIBA 09/2022 - 01/2021
2	HIPRA COVID-19 vaccineIBA 07/2023 - 05/2023
2	BNT162 VaccineIBA 05/2023 - 01/2022
2	COVID-19 VaccinesIBA 03/2023 - 01/2022
2	OligosaccharidesIBA 01/2023 - 04/2022
2	mRNA VaccinesIBA 11/2022 - 01/2022
2	Viral RNAIBA 11/2022 - 01/2022
2	Sialic Acid Binding Ig-like Lectin 1IBA 08/2022 - 12/2021
2	TubulinIBA 05/2022 - 10/2018
2	remdesivirIBA 07/2021 - 01/2021
2	Oxygen (Dioxygen)IBA 07/2021 - 01/2019
2	Immunoglobulin M (IgM)IBA 01/2020 - 01/2017
2	CytokinesIBA 04/2017 - 01/2017
2	HIV AntigensIBA 04/2015 - 02/2013
2	LigandsIBA 04/2011 - 03/2008
2	IntegrinsIBA 03/2008 - 03/2006
1	Peptides (Polypeptides)IBA 01/2024
1	CyclodextrinsIBA 08/2023
1	Interleukin-4 (Interleukin 4)IBA 05/2023
1	c-Mer Tyrosine KinaseIBA 05/2023
1	Interleukin-10 (Interleukin 10)IBA 05/2023
1	Conditioned Culture MediaIBA 05/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2023
1	Penicillins (Penicillin)FDA Link 01/2023
1	cyanovirin NIBA 01/2023
1	Polysaccharides (Glycans)IBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	ProteomeIBA 12/2022
1	Complement System Proteins (Complement)IBA 12/2022
1	LipidsIBA 12/2022
1	Immunoglobulins (Immunoglobulin)IBA 12/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 05/2022
1	Anti-Infective Agents (Microbicides)IBA 04/2022
1	Mannose (D-Mannose)IBA 04/2022
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2022
1	GlucocorticoidsIBA 01/2022
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2021
1	Mitogen Receptors (Mitogen Receptor)IBA 12/2021
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 12/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2021
1	CathepsinsIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Nelfinavir (Viracept)FDA Link 01/2021
1	Fenofibrate (CiL)FDA LinkGeneric 01/2021
1	plitidepsin (aplidine)IBA 01/2021
1	Drug CombinationsIBA 01/2021
1	camostatIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021

Therapy/Procedure

15	Therapeutics 11/2023 - 02/2006
4	Immunotherapy 05/2023 - 04/2017
4	Highly Active Antiretroviral Therapy (HAART) 03/2013 - 02/2006
3	Aftercare (After-Treatment) 12/2022 - 12/2013
1	Drug Therapy (Chemotherapy) 01/2023
1	Length of Stay 12/2022
1	Long-Term Care 01/2022